Somatostatin: a new therapeutic option for the treatment of chylothorax

Author： Buettiker V. Hug M. Burger R. Baenziger O.

ISSN： 0342-4642

Source： Intensive Care Medicine, Vol.27, Iss.6, 2001-06, pp. : 1083-1086

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Liraglutide: A New Option for the Treatment of Obesity

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 10, 2015-10 ,pp. : 926-934

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thiazolidinediones in the treatment of patients with Post-Transplant-Hyperglycemia or new-onset diabetes mellitus after renal transplantation (NODAT) – A new therapeutic option?

By Säemann Marcus D.

Wiener klinische Wochenschrift, Vol. 122, Iss. 7-8, 2010-04 ,pp. : 198-202

Springer Publishing Company

Access to resources Recommend Favorite

Repeated implantation failure: a new potential treatment option

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 4, 2015-04 ,pp. : 380-384

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of nitazoxanide as a new therapeutic option for persistent diarrhea: a pediatric perspective

By Cohen Stanley A.

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 999-1004

Informa Healthcare

Access to resources Recommend Favorite

Selective apheresis of C‐reactive protein: A new therapeutic option in myocardial infarction?

JOURNAL OF CLINICAL APHERESIS, Vol. 30, Iss. 1, 2015-02 ,pp. : 15-21

John Wiley & Sons Inc

Access to resources Recommend Favorite